MSKCC Memorial Sloan Kettering Cancer Center (MSKCC) is a flee-standing institution dedicated to the control of cancer through in-patient and out-patient care, clinical and research training programs, and a broad spectrum of research activities. MSKCC's research programs are grouped into three categories: Basic Research (Cellular Structure, Cell Signaling and Regulation, Developmental Biology, Genomic Integrity, and Molecular Structure); Bridge Disciplines (Cancer Biology and Experimental Pathology, Experimental Therapeutics, Immunology and Transplantation, and Imaging and Radiation Sciences), and Patient-Oriented Research (Clinical Research and Prevention, Control, and Population Research). The programs are designed to optimize the use of a large patient population and an extensive, multi-disciplinary staff of clinical and laboratory-based mvestigators and to encourage the application of discoveries in the basic sciences in a way that advances the 9revention, detection, diagnosis, and treatment of many forms of cancer. Scientific work in the eleven research programs depends on services provided by 36 core facilities, 20 of which will receive funding from the Cancer Center Support Grant (CCSG). During the next five years, under recently recruited leadership, MSKCC will enlarge its clinical and research facilities and its research and training programs; therefore, an expanded budget is requested to establish the laboratories of new investigators in several fields of inquiry and to develop additional core facilities.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA008748-42S4
Application #
7500961
Study Section
Subcommittee G - Education (NCI)
Program Officer
Shafik, Hasnaa
Project Start
1977-01-01
Project End
2007-12-31
Budget Start
2007-05-11
Budget End
2007-12-31
Support Year
42
Fiscal Year
2007
Total Cost
$218,450
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Griewank, Klaus G; Wiesner, Thomas; Murali, Rajmohan et al. (2018) Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1/2 and FAT1 mutations and similar DNA copy number alteration profiles. Mod Pathol 31:418-428
Drilon, Alexander; Fu, Siqing; Patel, Manish R et al. (2018) A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105. Cancer Discov :
Xu, Bin; Ghossein, Ronald A (2018) Crucial parameters in thyroid carcinoma reporting - challenges, controversies and clinical implications. Histopathology 72:32-39
Correa, D D; Kryza-Lacombe, M; Zhou, X et al. (2018) A pilot study of neuropsychological functions, APOE and amyloid imaging in patients with gliomas. J Neurooncol 136:613-622
Owosho, Adepitan A; Zhang, Lei; Rosenblum, Marc K et al. (2018) High sensitivity of FISH analysis in detecting homozygous SMARCB1 deletions in poorly differentiated chordoma: a clinicopathologic and molecular study of nine cases. Genes Chromosomes Cancer 57:89-95
Konishi, Tsuyoshi; Shimada, Yoshifumi; Hsu, Meier et al. (2018) Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome. JAMA Oncol 4:309-315
Escorcia, Freddy E; Steckler, Jeffrey M; Abdel-Atti, Dalya et al. (2018) Tumor-Specific Zr-89 Immuno-PET Imaging in a Human Bladder Cancer Model. Mol Imaging Biol 20:808-815
Yoon, Sam S (2018) The New American Joint Commission on Cancer Staging System for Soft Tissue Sarcomas: Splitting versus Lumping. Ann Surg Oncol 25:1101-1102
Turashvili, Gulisa; Morency, Elizabeth G; Kracun, Mihaela et al. (2018) Morphologic Features of Gastric-type Cervical Adenocarcinoma in Small Surgical and Cytology Specimens. Int J Gynecol Pathol :
Horvat, Natally; Veeraraghavan, Harini; Khan, Monika et al. (2018) MR Imaging of Rectal Cancer: Radiomics Analysis to Assess Treatment Response after Neoadjuvant Therapy. Radiology 287:833-843

Showing the most recent 10 out of 8799 publications